AI assistant
BiomX Inc. — Regulatory Filings 2026
Apr 10, 2026
35099_rf_2026-04-10_a4170c77-ef3e-48d7-9e5c-f2bcb90ce81a.zip
Regulatory Filings
Open in viewerOpens in your device viewer
Ex-Filing Fees
CALCULATION OF FILING FEE TABLES
S-8
BIOMX INC.
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Notes | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
|---|---|---|---|---|---|---|---|---|
| Equity | Common Stock, par value $0.0001 per share | (1) | Other | 1,390,000 | $ 2.75 | $ 3,822,500.00 | 0.0001381 | $ 527.89 |
| Total Offering Amounts: | $ 3,822,500.00 | 527.89 | ||||||
| Total Fee Offsets: | 0.00 | |||||||
| Net Fee Due: | $ 527.89 |
______ Offering Note(s)
(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of common stock of BiomX Inc. (the “Registrant”) that become issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant’s receipt of consideration that results in an increase in the number of the outstanding shares of the Registrant’s common stock. Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The proposed maximum offering price per share is based on $2.75 per share, which is the average of the high and low prices of the Registrant’s common stock as reported on the NYSE American on April 9, 2026. Fee Calculation Rule is “Other” pursuant to the Filing Fee Disclosure and Payment Methods Modernization rules adopted by the Securities and Exchange Commission. The fee is calculated in accordance with Rules 457(c) and 457(h) under the Securities Act. Represents shares of the Registrant’s common stock issuable pursuant to awards granted or to be granted under the BiomX Inc. 2026 Equity Incentive Plan.